Olaplex Buys Biotech Firm, Stock Dips: Risky Move?

Olaplex dives into biotech! Find out why the haircare giant's stock plunged after acquiring Purvala Bioscience, a molecular development firm. Is this a risky move or a stroke of genius? We break down Wall Street's concerns, Olaplex's volatile year, and whether this acquisition can revive the company's long-term potential. Hosted on Acast. See acast.com/privacy for more information.